SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000899140-04-000547
Filing Date
2004-04-21
Accepted
2004-04-21 15:58:56
Documents
5
Group Members
WARBURG PINCUS & CO.WARBURG PINCUS LLC

Document Format Files

Seq Description Document Type Size
1 INITIAL FILING ON SCHEDULE 13D w1354245b.txt SC 13D 46509
4 JOINT FILING AGREEMENT w1354245c.txt EX-1 1679
5 SECURITIES PURCHASE AGREEMENT w1354245.txt EX-2 131866
6 LETTER AGREEMENT w1355516.txt EX-3 8531
7 LETTER AGREEMENT w2530280.txt EX-4 5863
  Complete submission text file 0000899140-04-000547.txt   196947
Mailing Address 35 NORTHEAST INDUSTRIAL RD BRANFORD CT 06405
Business Address 35 NORTHEAST INDUSTRIAL RD BRANFORD CT 06405 2034888201
NEUROGEN CORP (Subject) CIK: 0000849043 (see all company filings)

IRS No.: 222845714 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-41776 | Film No.: 04745578
SIC: 2834 Pharmaceutical Preparations

Mailing Address 466 LEXINGTON AVENUE NEW YORK NY 10017
Business Address 466 LEXINGTON AVENUE NEW YORK NY 10017 2128780600
WARBURG PINCUS PRIVATE EQUITY VIII L P (Filed by) CIK: 0001157334 (see all company filings)

IRS No.: 134161869 | State of Incorp.: DE | Fiscal Year End: 1231